RxElite Operating Income

The latest operating income for RXEI is $10M as of September 2008. That compares with $3.1M in the prior-year period — up 233.9% year over year. Investors often review this figure alongside RxElite's historical trend and sector peers before judging valuation or financial health.

Over the past year, RXEI's operating income moved from $3.1M to $10M — a 233.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in RxElite's operating scale or balance-sheet position.

A operating income figure of $10M for RXEI is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting RXEI's operating income ($10M), review year-over-year change from $3.1M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.